Close Menu

high-content screening

The partners will provide drug discovery services, expertise, and infrastructure in a new AMRI center located in the Buffalo Medical Innovation and Commercialization Hub.

NEW YORK (GenomeWeb News) – The Sanford-Burnham Medical Research Institute said today that its investigators will collaborate with Pfizer to identify therapeutic targets for use in preventing and treating complications related to obesity and diabetes.

NEW YORK (GenomeWeb News) – Cenix BioScience and Debiopharm Group today announced a research agreement to use Cenix's technology in support of Debiopharm's drug development efforts.

This story was originally posted on Oct. 18
Cytoo, a French life sciences tools provider, will soon launch a microplate version of its CytooChips Motility chip for studying cell migration, according to a company spokeperson.

Sony DADC and Maven Biotechnologies announced Wednesday a collaboration to develop and manufacture smart consumables for Maven's platform for performing cell-based assays and multiplexed biomarker detection.

NEW YORK (GenomeWeb News) – French cell-based assays developer Cytoo said this week that it has raised $10 million in a Series C financing round.

Pharmaceutical firm SuperGen will have limited access to Molecular Response's "living" cell bank of primary tumor cells, high-content imaging, and molecular characterization platforms.

Molecular Devices will distribute the software to customers in the research and pharmaceutical markets worldwide.

The acquisition is expect to "significantly strengthen" Apredica's high-content toxicology offerings.

Pages

The Lancet has made changes to its peer-review process in response to its recent retraction of a COVID-19-related paper, Science reports.

The New York Times reports that a series of emails show how Department of Health and Human Services officials sought to silence the Centers for Disease Control and Prevention.

A new initiative aims to move Australia's genome sequencing labs onto one system, the Sydney Morning Herald reports.

In PLOS this week: recessive mutation tied to early-onset dilated cardiomyopathy, epigenetic analysis of lung adenocarcinoma, and more.